On August 14, Aehr Test rose 8.27% in pre-market trading, trading at $133.5/share, with turnover of $2.7524 million.

On the news front, investment bank Jefferies initiated coverage of the company with a Buy rating and a $175 price target, significantly above the prior analyst consensus target of $127. The $175 target implies approximately 31% upside from the current stock price, substantially boosting market sentiment.

The initiation comes amid strong business momentum. The company disclosed a $22 million follow-on production order from its lead wafer-level AI processor customer on August 12, involving multiple fully automated FOX-XP systems to be delivered within six months to a high-volume manufacturing partner in Taiwan. Earlier, the company also received a follow-on order from its lead silicon photonics customer. The business structure has undergone significant transformation, with AI data center-related revenue projected to account for approximately 70% of fiscal year 2027 total revenue, reinforcing market expectations for sustained high growth in the AI test equipment segment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)